Renaissance Technologies - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 150 filers reported holding ANIKA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,966
-33.3%
588,629
-7.0%
0.02%
-20.8%
Q2 2023$16,451
-0.5%
633,229
+10.0%
0.02%
+9.1%
Q1 2023$16,526
-6.3%
575,417
-3.4%
0.02%
-8.3%
Q4 2022$17,628
-99.9%
595,529
-6.4%
0.02%
+14.3%
Q3 2022$15,149,000
-3.8%
636,517
-9.8%
0.02%
+10.5%
Q2 2022$15,754,000
-7.2%
705,817
+4.4%
0.02%
-5.0%
Q1 2022$16,980,000
-30.7%
676,217
-1.1%
0.02%
-33.3%
Q4 2021$24,487,000
-18.3%
683,417
-2.9%
0.03%
-23.1%
Q3 2021$29,963,000
-3.7%
704,017
-2.0%
0.04%0.0%
Q2 2021$31,113,000
+2.4%
718,717
-3.5%
0.04%
+2.6%
Q1 2021$30,389,000
-17.0%
745,017
-7.9%
0.04%
-5.0%
Q4 2020$36,621,000
+23.7%
809,117
-3.3%
0.04%
+33.3%
Q3 2020$29,604,000
-6.0%
836,517
+0.2%
0.03%
+11.1%
Q2 2020$31,501,000
+45.7%
834,917
+11.6%
0.03%
+28.6%
Q1 2020$21,620,000
-28.7%
747,829
+27.8%
0.02%
-8.7%
Q4 2019$30,339,000
+14.5%
585,129
+21.2%
0.02%
+4.5%
Q3 2019$26,508,000
+46.9%
482,922
+8.7%
0.02%
+37.5%
Q2 2019$18,044,000
+63.3%
444,222
+21.6%
0.02%
+60.0%
Q1 2019$11,050,000
+24.9%
365,410
+38.9%
0.01%0.0%
Q4 2018$8,844,000
-22.4%
263,133
-2.6%
0.01%
-16.7%
Q3 2018$11,394,000
-43.6%
270,126
-48.0%
0.01%
+9.1%
Q2 2018$20,208,000
+101.1%
519,600
+157.1%
0.01%0.0%
Q1 2018$10,048,000
+69.9%
202,100
+84.2%
0.01%
+57.1%
Q4 2017$5,914,000
-11.1%
109,700
-4.4%
0.01%
-12.5%
Q3 2017$6,653,000
-6.9%
114,700
-20.8%
0.01%
-11.1%
Q2 2017$7,149,000
-35.0%
144,900
-42.7%
0.01%
-40.0%
Q1 2017$10,995,000
+34.6%
253,100
+51.7%
0.02%
+15.4%
Q4 2016$8,167,000
-17.8%
166,800
-19.7%
0.01%
-27.8%
Q3 2016$9,938,000
-31.7%
207,700
-23.4%
0.02%
-35.7%
Q2 2016$14,545,000
+8.3%
271,100
-9.8%
0.03%
+7.7%
Q1 2016$13,434,000
+211.5%
300,400
+165.8%
0.03%
+188.9%
Q4 2015$4,312,000
+152.8%
113,000
+110.8%
0.01%
+125.0%
Q3 2015$1,706,000
-55.9%
53,600
-54.3%
0.00%
-55.6%
Q2 2015$3,871,000
-16.4%
117,200
+4.2%
0.01%
-10.0%
Q1 2015$4,632,000
-46.6%
112,500
-47.1%
0.01%
-52.4%
Q4 2014$8,669,000
-12.6%
212,800
-21.4%
0.02%
-22.2%
Q3 2014$9,920,000
-41.7%
270,600
-26.3%
0.03%
-32.5%
Q2 2014$17,022,000
-6.4%
367,400
-17.0%
0.04%
-9.1%
Q1 2014$18,183,000
+20.1%
442,400
+11.5%
0.04%
+22.2%
Q4 2013$15,142,000
+57.6%
396,800
-1.3%
0.04%
+56.5%
Q3 2013$9,606,000
+52.4%
402,100
+8.5%
0.02%
+35.3%
Q2 2013$6,302,000370,7030.02%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Caligan Partners LP 1,081,360$20,145,7379.25%
Trigran Investments, Inc. 2,217,019$41,303,0654.40%
DIKER MANAGEMENT LLC 50,239$935,9530.84%
Virtus Investment Advisers, Inc. 45,579$849,1370.58%
Virtus Fund Advisers, LLC 3,490$65,0190.46%
CAPITAL MANAGEMENT CORP /VA 84,225$1,569,1120.35%
Riverwater Partners LLC 17,597$327,8320.30%
BOOTHBAY FUND MANAGEMENT, LLC 617,602$11,505,9250.27%
XTX Topco Ltd 28,033$522,2550.09%
GSA CAPITAL PARTNERS LLP 51,638$9620.08%
View complete list of ANIKA THERAPEUTICS INC shareholders